Chris Froome, the four-time Tour de France winning British cyclist, has been cleared of any wrongdoing in an anti-drug investigation by the UCI and WADA.
Froome back on for France
In a case that has been in progress since September 2018, the announcement came on Monday morning that Froome had no case to answer regarding the drug salbutamol. The decision means that the rider will not have his 2017 Vuelta de España title taken away from him.
The other important result is that Froome will compete to win a fifth Tour de France crown which gets underway on Saturday, July 7. Froome, 33, had tested positive for excessive levels of Salbutamol following a urine sample at last September's Vuelta a Espana.
Grateful and relieved to finally put this chapter behind me, it has been an emotional 9 months. Thank you to all of those who have supported and believed in me throughout. pic.twitter.com/OGzsg83Gjj— Chris Froome (@chrisfroome) 2 July 2018
"On 28 June 2018, World Anti-Doping Agency (WADA) informed the UCI that it would accept, based on the specific facts of the case, that Mr Froome’s sample results do not constitute an Adverse Analytical Finding," the UCI said in a statement.
"In light of WADA's unparalleled access to information and authorship of the salbutamol regime, the UCI has decided, based on WADA’s position, to close the proceedings against Mr Froome."